Literature DB >> 31063838

Fabrication of doxycycline-loaded electrospun PCL/PEO membranes for a potential drug delivery system.

Ş Melda Eskitoros-Togay1, Y Emre Bulbul1, Serdar Tort2, Funda Demirtaş Korkmaz3, Füsun Acartürk2, Nursel Dilsiz4.   

Abstract

Potential usage of biodegradable and biocompatible polymeric nanofibers is the most attention grabbing topic for the drug delivery system. In order to fabricate ultrafine fibers, electrospinning, one of the well-known techniques, has been extensively studied in the literature. In the present study, the objective is to achieve the optimum blend of hydrophobic and hydrophilic polymers to be used as a drug delivery vehicle and also to obtain the optimum amount of doxycycline (DOXH) to reach the optimum release. In this case, the biodegradable and biocompatible synthetic polymers, poly(ε-caprolactone) (PCL) and poly(ethylene oxide) (PEO), were blended with different ratios for the production of DOXH-loaded electrospun PCL/PEO membranes using electrospinning technique, which is a novel attempt. The fabricated membranes were subsequently characterized to optimize the blending ratio of polymers by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD) and water contact angle analysis. After the characterization studies, different amounts of DOXH were loaded to the optimized blend of PCL and PEO to investigate the release of DOXH from the membrane used as a drug delivery vehicle. In vitro drug release studies were performed, and in vitro drug release kinetics were assessed to confirm the usage of these nanofiber materials as efficient drug delivery vehicles. The results indicated that 3.5% DOXH-loaded (75:25 w/w) PCL/PEO is the most acceptable membrane to provide prolonged release rather than immediate release of DOXH.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Doxycycline; Drug delivery vehicle; Electrospinning; Nanofiber; Polycaprolactone; Polyethylene oxide

Mesh:

Substances:

Year:  2019        PMID: 31063838     DOI: 10.1016/j.ijpharm.2019.04.073

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Novel calcium phosphate cement with biofilm-inhibition and platelet lysate delivery to enhance osteogenesis of encapsulated human periodontal ligament stem cells.

Authors:  Gengtao Qiu; Hansen Wu; Mingguang Huang; Tao Ma; Abraham Schneider; Thomas W Oates; Michael D Weir; Hockin H K Xu; Liang Zhao
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-10

2.  Preparation, optimization, and in vitro-in vivo evaluation of sorafenib-loaded polycaprolactone and cellulose acetate nanofibers for the treatment of cutaneous leishmaniasis.

Authors:  Mahsa Alemomen; Somayeh Taymouri; Sedigheh Saberi; Jaleh Varshosaz
Journal:  Drug Deliv Transl Res       Date:  2022-10-12       Impact factor: 5.671

3.  Development of an antibacterial and anti-metalloproteinase dental adhesive for long-lasting resin composite restorations.

Authors:  Eliseu A Münchow; Adriana F da Silva; Evandro Piva; Carlos E Cuevas-Suárez; Maria T P de Albuquerque; Rodolfo Pinal; Richard L Gregory; Lorenzo Breschi; Marco C Bottino
Journal:  J Mater Chem B       Date:  2020-11-10       Impact factor: 6.331

4.  Fibrous Materials Made of Poly(ε-caprolactone)/Poly(ethylene oxide)-b-Poly(ε-caprolactone) Blends Support Neural Stem Cells Differentiation.

Authors:  Daniel Fernández; Montserrat Guerra; Judit G Lisoni; Thomas Hoffmann; Rodrigo Araya-Hermosilla; Toshimichi Shibue; Hiroyuki Nishide; Ignacio Moreno-Villoslada; Mario E Flores
Journal:  Polymers (Basel)       Date:  2019-10-08       Impact factor: 4.329

5.  Bacterially sensitive nanoparticle-based dissolving microneedles of doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study.

Authors:  Andi Dian Permana; Maria Mir; Emilia Utomo; Ryan F Donnelly
Journal:  Int J Pharm X       Date:  2020-04-14

6.  Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer.

Authors:  Yiran Zhang; Yanming Wang; Li Meng; Qingqing Huang; Yueqi Zhu; Wenguo Cui; Yingsheng Cheng; Ranlu Liu
Journal:  J Nanobiotechnology       Date:  2021-01-09       Impact factor: 10.435

Review 7.  Nature-Derived and Synthetic Additives to poly(ɛ-Caprolactone) Nanofibrous Systems for Biomedicine; an Updated Overview.

Authors:  Shahin Homaeigohar; Aldo R Boccaccini
Journal:  Front Chem       Date:  2022-01-19       Impact factor: 5.221

Review 8.  Research progress, models and simulation of electrospinning technology: a review.

Authors:  Yajin Guo; Xinyu Wang; Ying Shen; Kuo Dong; Linyi Shen; Asmaa Ahmed Abdullah Alzalab
Journal:  J Mater Sci       Date:  2021-10-13       Impact factor: 4.220

Review 9.  Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization.

Authors:  Yue Sun; Shihong Cheng; Wenjuan Lu; Yanfeng Wang; Pingping Zhang; Qingqiang Yao
Journal:  RSC Adv       Date:  2019-08-15       Impact factor: 4.036

10.  Preparation and Characterization of Doxycycline-Loaded Electrospun PLA/HAP Nanofibers as a Drug Delivery System.

Authors:  Noémi-Izabella Farkas; Laura Marincaș; Réka Barabás; Liliana Bizo; Aranka Ilea; Graziella Liana Turdean; Monica Toșa; Oana Cadar; Lucian Barbu-Tudoran
Journal:  Materials (Basel)       Date:  2022-03-12       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.